Therapeutic angiogenesis: A case for targeted, regulated gene delivery

Critical Reviews in Eukaryotic Gene Expression

Volumn 10, Issue 2, 2000, Pages 113-125

  Webster, K A ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

Gene therapy; Hypoxia; Limb ischemia; Myocardial ischemia

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; PLASMID DNA; RECOMBINANT FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN; VIRUS VECTOR;

ACUTE HEART INFARCTION; AGED; ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CASE REPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE THERAPY; GENE TRANSFER; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALIA;

EID: 0033758113     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/critreveukargeneexpr.v10.i2.10     Document Type: Review

References (71)

1. Gene transfer and models of gene therapy for the myocardium
2. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: Up-regulation of essential transcription factor for angiogenesis, ets
3. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis
4. Tei2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnatal neovascularization
5. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose response effect of basic fibroblast growth factor
6. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
7. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
8. Silent Ischemia: Mechanisms, diagnosis, and prevalence
9. Mechanisms of angiogenesis and arteriogenesis
10. Basic FGF enhances the development of the collateral circulation after acute arterial occlusion
11. A mouse model of angiogenesis
12. Transient ST-segment depression as a marker of myocardial ischemia during daily life
13. Silent ischemia during daily life is an independent predictor of mortality in stable angina
14. Conditional silencing as a means to suppress basal expression and augment the therapeutic differential of gene therapy vectors targeted to ischemic tissues
15. Experimental use of a modified fibrin-glue to induce site-directed angiogenesis from the aorta to the heart
16. The vascular endothelial growth factor family of polypeptides
17. Apoptosis in ischemic and reperfused rat myocardium
18. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes
19. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
20. Synergistic effects of vascular endothelial growth factor and basic growth factor in the induction of angiogenesis in vitro
21. Reperfusion injury induces apoptosis in rabbit cardiomyocytes
22. Scatter factor induces blood vessel formation in vivo
23. Phase 1 adenovirus gene transfer studies look good
24. Limb or myocardial ischemia treatment with naked DNA
25. Prostanoids for chronic leg ischemia: A randomized, controlled, open-label trial with prostaglandin E1
26. Arterial gene therapy in patients with peripheral artery disease
27. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF in patients with ischaemic limb
28. Manipulating angiogenesis against vascular disease
29. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal vascularization
30. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis
31. Expression of hepatocyte growth factor in growing and regenerating skeletal muscle
32. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
33. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
34. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus
35. Effects of chronic administration of basic fibroblast growth factor in collateral development in the canine heart
36. Angiogenesis by gene therapy: A new horizon for myocardial revascularization
37. The global burden of disease, 1990-2020
38. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
39. Perioperative cardiac morbidity
40. Gene therapy for collateral vessel development
41. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction
42. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo
43. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors
44. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
45. Angiostatin induces and sustains dormancy of human primary tumors in mice
46. 'Apoptotic' myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: Analysis by immuno-gold electron microscopy combined with in situ nick end-labeling
47. Regulated expression of a foreign gene targeted to the ischemic myocardium
48. Myocardial ischemia and infarction: Anatomic and biochemical substrates for ischemic cell death and ventricular arrhythmias
49. Age-dependent impairment of angiogenesis
50. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene transfer with Adeno-VEGF
51. Apoptosis in human acute myocardial infarction
52. Critical limb ischemia: Nothing to give at the office
53. Growth of new coronary vascular structures by angiogenic growth factors
54. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
55. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in rabbit ischemic hindlimb
56. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
57. Scatter factor/hepatocyte growth factor and its receptor c-met can mediate signal exchange between mesenchyme and epithelia during mouse development
58. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated vires vectors
59. Pathophysiology of Myocardial Infarction and Ischemia
60. Vascular endothelial growth factor induces dose-dependent revascularization in a rabbit model of persistent limb ischemia
61. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model
62. Apoptosis in pressure overload-induced heart hypertrophy in the rat
63. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium
64. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
65. Late out-come of amputees with premature atherosclerosis
66. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of VEGF
67. One-step, two step regulation of therapeutic genes
68. Molecular switches for regulating therapeutic genes
69. Determination of tissue distribution of an intramuscular plasmid vaccine using PCR and In Situ DNA hybridization
70. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
71. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer